Literature DB >> 33673524

The Dying Forward Hypothesis of ALS: Tracing Its History.

Andrew Eisen1.   

Abstract

The site of origin of amyotrophic lateral sclerosis (ALS), although unsettled, is increasingly recognized as being cortico-fugal, which is a dying-forward process primarily starting in the corticomotoneuronal system. A variety of iterations of this concept date back to over 150 years. Recently, the hallmark TAR DNA-binding protein 43 (TDP-43) pathology, seen in >95% of patients with ALS, has been shown to be largely restricted to corticofugal projecting neurons ("dying forward"). Possibly, soluble but toxic cytoplasmic TDP-43 could enter the axoplasm of Betz cells, subsequently causing dysregulation of nuclear protein in the lower brainstem and spinal cord anterior horn cells. As the disease progresses, cortical involvement in ALS becomes widespread, including or starting with frontotemporal dementia, implying a broader view of ALS as a brain disease. The onset at the motor and premotor cortices should be considered a nidus at the edge of multiple cortical networks which eventually become disrupted, causing failure of a widespread cortical connectome.

Entities:  

Keywords:  TDP-43; amyotrophic lateral sclerosis; dying-forward; frontotemporal dementia; neural networks; neurodegeneration

Year:  2021        PMID: 33673524      PMCID: PMC7997258          DOI: 10.3390/brainsci11030300

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  72 in total

Review 1.  The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Authors:  F Agosta; A Chiò; M Cosottini; N De Stefano; A Falini; M Mascalchi; M A Rocca; V Silani; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

2.  Assessment of cortical excitability using threshold tracking techniques.

Authors:  Steve Vucic; James Howells; Louise Trevillion; Matthew C Kiernan
Journal:  Muscle Nerve       Date:  2006-04       Impact factor: 3.217

3.  Subdivisions of primary motor cortex based on cortico-motoneuronal cells.

Authors:  Jean-Alban Rathelot; Peter L Strick
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-12       Impact factor: 11.205

4.  Cortical magnetic stimulation in amyotrophic lateral sclerosis.

Authors:  A Eisen; W Shytbel; K Murphy; M Hoirch
Journal:  Muscle Nerve       Date:  1990-02       Impact factor: 3.217

5.  The "extraverted neurons" of the mammalian cerebral cortex.

Authors:  F Sanides; D Sanides
Journal:  Z Anat Entwicklungsgesch       Date:  1972

Review 6.  Is it accurate to classify ALS as a neuromuscular disorder?

Authors:  Michael A van Es; H Stephan Goedee; Henk-Jan Westeneng; Tanja C W Nijboer; Leonard H van den Berg
Journal:  Expert Rev Neurother       Date:  2020-09-01       Impact factor: 4.618

7.  Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.

Authors:  Steve Vucic; Garth A Nicholson; Matthew C Kiernan
Journal:  Brain       Date:  2008-05-09       Impact factor: 13.501

8.  Involvement of the external anal sphincter in amyotrophic lateral sclerosis.

Authors:  M Carvalho; M S Schwartz; M Swash
Journal:  Muscle Nerve       Date:  1995-08       Impact factor: 3.217

9.  Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis.

Authors:  Domenico Maria Mezzapesa; Eustachio D'Errico; Rosanna Tortelli; Eugenio Distaso; Rosa Cortese; Marianna Tursi; Francesco Federico; Stefano Zoccolella; Giancarlo Logroscino; Franca Dicuonzo; Isabella Laura Simone
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

10.  ALS--dying forward, backward or outward?

Authors:  Mark R Baker
Journal:  Nat Rev Neurol       Date:  2014-09-23       Impact factor: 42.937

View more
  11 in total

Review 1.  Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Sagar Verma; Shiffali Khurana; Abhishek Vats; Bandana Sahu; Nirmal Kumar Ganguly; Pradip Chakraborti; Mandaville Gourie-Devi; Vibha Taneja
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

Review 2.  Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy.

Authors:  Michael P Coleman
Journal:  Neurotherapeutics       Date:  2022-10-07       Impact factor: 6.088

3.  Cognitive impairment in ALS has been known since the nineteenth century.

Authors:  Philippe Corcia; Philippe Couratier
Journal:  Neurol Sci       Date:  2022-09-30       Impact factor: 3.830

4.  Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis.

Authors:  Matthew J Broadhead; Calum Bonthron; Julia Waddington; William V Smith; Maite F Lopez; Sarah Burley; Jessica Valli; Fei Zhu; Noboru H Komiyama; Colin Smith; Seth G N Grant; Gareth B Miles
Journal:  Acta Neuropathol       Date:  2022-03-19       Impact factor: 15.887

Review 5.  Adaptive Remodeling of the Neuromuscular Junction with Aging.

Authors:  Michael R Deschenes; Rachel Flannery; Alexis Hawbaker; Leah Patek; Mia Mifsud
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

Review 6.  The strength of corticomotoneuronal drive underlies ALS split phenotypes and reflects early upper motor neuron dysfunction.

Authors:  Andrew Eisen; Peter Bede
Journal:  Brain Behav       Date:  2021-10-28       Impact factor: 2.708

7.  Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis.

Authors:  Ario Mirian; Alexander Moszczynski; Serena Soleimani; Isabelle Aubert; Lorne Zinman; Agessandro Abrahao
Journal:  Front Cell Neurosci       Date:  2022-03-31       Impact factor: 5.505

Review 8.  The Cortical "Upper Motoneuron" in Health and Disease.

Authors:  Roger N Lemon
Journal:  Brain Sci       Date:  2021-05-12

9.  Cytoplasmic Human TDP-43 Mislocalization Induces Widespread Dendritic Spine Loss in Mouse Upper Motor Neurons.

Authors:  Marcus S Dyer; Adele Woodhouse; Catherine A Blizzard
Journal:  Brain Sci       Date:  2021-06-30

Review 10.  The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease.

Authors:  Shama R Iyer; Sameer B Shah; Richard M Lovering
Journal:  Int J Mol Sci       Date:  2021-07-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.